Mark Noble1. Show Affiliations » 1. Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY 14642, USA. mark_noble@urmc.rochester.edu
Abstract
Entities: Disease
Mesh: See more » 4-Aminopyridine/therapeutic useAlzheimer Disease/etiologyAlzheimer Disease/metabolismAlzheimer Disease/therapyAnimalsAntibodies/therapeutic useCentral Nervous System/metabolismCentral Nervous System/pathologyDemyelinating Diseases/complicationsDemyelinating Diseases/drug therapyGlial Cell Line-Derived Neurotrophic FactorHumansMyelin Sheath/metabolismMyelin Sheath/pathologyNerve Growth Factors/therapeutic useOligodendroglia/drug effectsOligodendroglia/metabolismPotassium Channel Blockers/therapeutic use
Substances: See more » AntibodiesGDNF protein, humanGlial Cell Line-Derived Neurotrophic FactorNerve Growth FactorsPotassium Channel Blockers4-Aminopyridine
Year: 2004 PMID: 14675726 DOI: 10.1016/j.neurobiolaging.2003.07.001
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673